Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation

Lungisa Bickle, John J. Hopwood, Litsa Karageorgos

Research output: Contribution to journalArticle

Abstract

Parkinson's disease (PD) presents with neuropathological inclusions called Lewy bodies, which are primarily composed of fibrillar α-synuclein. Recently, we characterized sheep with Gaucher disease and since GBA1 mutations represent the highest genetic risk factor for PD, we have investigated α-synuclein fibrillation in the sheep. Here we demonstrate that differences in six amino acid residues between sheep and human α-synuclein significantly alter in vitro fibril formation. Circular dichroism of recombinant human and sheep α-synuclein show that both proteins adopt the same secondary structure. Fibrils from human and sheep α-synuclein formed at pH 7.0 or 4.5 were analyzed by Transmission Electron Microscopy (TEM). Unexpectedly, sheep α-synuclein form fibrils much less readily than human α-synuclein and this difference was more pronounced at the lysosomal pH of 4.5. Aggregation-propensity and intrinsic-solubility analysis revealed that sheep α-synuclein had lower aggregation-propensity and higher solubility. As a result of these observations, TEM was used to analyze fibrils formed at pH 4.5 of various “sheep-like” human or “human-like” sheep mutant α-synucleins, together with their wild-type forms. Thioflavin T was used to monitor in situ α-synuclein fibril formation at pH 7.0 and 4.5. Results show that “sheep-like” human α-synuclein has substantially lower fibril aggregation, and “human-like” sheep α-synuclein aggregates faster than wild-type forms, respectively. Seeding with WT human α-synuclein showed that “sheep-like” human α-synuclein could not be seeded, providing further evidence that sheep sequence is resistant to fibrillation. These findings provide new avenues to prevent/reduce fibrillation in PD, which may aid in the development of therapies.

LanguageEnglish
Pages261-273
Number of pages13
JournalBiochimica et Biophysica Acta - Proteins and Proteomics
Volume1865
Issue number3
DOIs
Publication statusPublished - 1 Mar 2017

Keywords

  • Aggregation
  • Amyloid
  • Fibril
  • Parkinson's disease
  • α-Synuclein

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biophysics
  • Biochemistry
  • Molecular Biology

Cite this

Bickle, Lungisa ; Hopwood, John J. ; Karageorgos, Litsa. / Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation. In: Biochimica et Biophysica Acta - Proteins and Proteomics. 2017 ; Vol. 1865, No. 3. pp. 261-273.
@article{7d6cb02e2cac4b268b4b2d0f5cbe1983,
title = "Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation",
abstract = "Parkinson's disease (PD) presents with neuropathological inclusions called Lewy bodies, which are primarily composed of fibrillar α-synuclein. Recently, we characterized sheep with Gaucher disease and since GBA1 mutations represent the highest genetic risk factor for PD, we have investigated α-synuclein fibrillation in the sheep. Here we demonstrate that differences in six amino acid residues between sheep and human α-synuclein significantly alter in vitro fibril formation. Circular dichroism of recombinant human and sheep α-synuclein show that both proteins adopt the same secondary structure. Fibrils from human and sheep α-synuclein formed at pH 7.0 or 4.5 were analyzed by Transmission Electron Microscopy (TEM). Unexpectedly, sheep α-synuclein form fibrils much less readily than human α-synuclein and this difference was more pronounced at the lysosomal pH of 4.5. Aggregation-propensity and intrinsic-solubility analysis revealed that sheep α-synuclein had lower aggregation-propensity and higher solubility. As a result of these observations, TEM was used to analyze fibrils formed at pH 4.5 of various “sheep-like” human or “human-like” sheep mutant α-synucleins, together with their wild-type forms. Thioflavin T was used to monitor in situ α-synuclein fibril formation at pH 7.0 and 4.5. Results show that “sheep-like” human α-synuclein has substantially lower fibril aggregation, and “human-like” sheep α-synuclein aggregates faster than wild-type forms, respectively. Seeding with WT human α-synuclein showed that “sheep-like” human α-synuclein could not be seeded, providing further evidence that sheep sequence is resistant to fibrillation. These findings provide new avenues to prevent/reduce fibrillation in PD, which may aid in the development of therapies.",
keywords = "Aggregation, Amyloid, Fibril, Parkinson's disease, α-Synuclein",
author = "Lungisa Bickle and Hopwood, {John J.} and Litsa Karageorgos",
year = "2017",
month = "3",
day = "1",
doi = "10.1016/j.bbapap.2016.12.008",
language = "English",
volume = "1865",
pages = "261--273",
journal = "Biochimica et Biophysica Acta - Proteins and Proteomics",
issn = "1570-9639",
publisher = "Elsevier",
number = "3",

}

Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation. / Bickle, Lungisa; Hopwood, John J.; Karageorgos, Litsa.

In: Biochimica et Biophysica Acta - Proteins and Proteomics, Vol. 1865, No. 3, 01.03.2017, p. 261-273.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Analysis of sheep α-synuclein provides a molecular strategy for the reduction of fibrillation

AU - Bickle, Lungisa

AU - Hopwood, John J.

AU - Karageorgos, Litsa

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Parkinson's disease (PD) presents with neuropathological inclusions called Lewy bodies, which are primarily composed of fibrillar α-synuclein. Recently, we characterized sheep with Gaucher disease and since GBA1 mutations represent the highest genetic risk factor for PD, we have investigated α-synuclein fibrillation in the sheep. Here we demonstrate that differences in six amino acid residues between sheep and human α-synuclein significantly alter in vitro fibril formation. Circular dichroism of recombinant human and sheep α-synuclein show that both proteins adopt the same secondary structure. Fibrils from human and sheep α-synuclein formed at pH 7.0 or 4.5 were analyzed by Transmission Electron Microscopy (TEM). Unexpectedly, sheep α-synuclein form fibrils much less readily than human α-synuclein and this difference was more pronounced at the lysosomal pH of 4.5. Aggregation-propensity and intrinsic-solubility analysis revealed that sheep α-synuclein had lower aggregation-propensity and higher solubility. As a result of these observations, TEM was used to analyze fibrils formed at pH 4.5 of various “sheep-like” human or “human-like” sheep mutant α-synucleins, together with their wild-type forms. Thioflavin T was used to monitor in situ α-synuclein fibril formation at pH 7.0 and 4.5. Results show that “sheep-like” human α-synuclein has substantially lower fibril aggregation, and “human-like” sheep α-synuclein aggregates faster than wild-type forms, respectively. Seeding with WT human α-synuclein showed that “sheep-like” human α-synuclein could not be seeded, providing further evidence that sheep sequence is resistant to fibrillation. These findings provide new avenues to prevent/reduce fibrillation in PD, which may aid in the development of therapies.

AB - Parkinson's disease (PD) presents with neuropathological inclusions called Lewy bodies, which are primarily composed of fibrillar α-synuclein. Recently, we characterized sheep with Gaucher disease and since GBA1 mutations represent the highest genetic risk factor for PD, we have investigated α-synuclein fibrillation in the sheep. Here we demonstrate that differences in six amino acid residues between sheep and human α-synuclein significantly alter in vitro fibril formation. Circular dichroism of recombinant human and sheep α-synuclein show that both proteins adopt the same secondary structure. Fibrils from human and sheep α-synuclein formed at pH 7.0 or 4.5 were analyzed by Transmission Electron Microscopy (TEM). Unexpectedly, sheep α-synuclein form fibrils much less readily than human α-synuclein and this difference was more pronounced at the lysosomal pH of 4.5. Aggregation-propensity and intrinsic-solubility analysis revealed that sheep α-synuclein had lower aggregation-propensity and higher solubility. As a result of these observations, TEM was used to analyze fibrils formed at pH 4.5 of various “sheep-like” human or “human-like” sheep mutant α-synucleins, together with their wild-type forms. Thioflavin T was used to monitor in situ α-synuclein fibril formation at pH 7.0 and 4.5. Results show that “sheep-like” human α-synuclein has substantially lower fibril aggregation, and “human-like” sheep α-synuclein aggregates faster than wild-type forms, respectively. Seeding with WT human α-synuclein showed that “sheep-like” human α-synuclein could not be seeded, providing further evidence that sheep sequence is resistant to fibrillation. These findings provide new avenues to prevent/reduce fibrillation in PD, which may aid in the development of therapies.

KW - Aggregation

KW - Amyloid

KW - Fibril

KW - Parkinson's disease

KW - α-Synuclein

UR - http://www.scopus.com/inward/record.url?scp=85006756996&partnerID=8YFLogxK

U2 - 10.1016/j.bbapap.2016.12.008

DO - 10.1016/j.bbapap.2016.12.008

M3 - Article

VL - 1865

SP - 261

EP - 273

JO - Biochimica et Biophysica Acta - Proteins and Proteomics

T2 - Biochimica et Biophysica Acta - Proteins and Proteomics

JF - Biochimica et Biophysica Acta - Proteins and Proteomics

SN - 1570-9639

IS - 3

ER -